Juno Therapeutics, Inc.

Robbins LLP Is Investigating the Officers and Directors of Juno Therapeutics, Inc. (JUNO) on Behalf of Shareholders

Robbins LLP is investigating whether certain officers and directors of Juno Therapeutics, Inc. (NasdaqGS: JUNO) breached their fiduciary duties to shareholders. Juno, a biopharmaceutical company, engages in developing cell-based cancer immunotherapies.

Juno Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact us via the form below and we will contact you directly.

Send us a message for more information.

Skip to content